Abstract
The present study was designed to evaluate the effect of palmatine on memory of Swiss young male albino mice. Palmatine (0.1, 0.5, 1 mg/kg, i.p.) and physostigmine (0.1 mg/kg, i.p.) per se were administered for 10 successive days to separate groups of mice. Effect of drugs on learning and memory of mice was evaluated using elevated plus maze and Morris water maze. Brain acetylcholinesterase activity was also estimated. Effect of palmatine on scopolamine- and diazepam-induced amnesia was also investigated. Palmatine (0.5 and 1 mg/kg) and physostigmine significantly improved learning and memory of mice, as indicated by decrease in transfer latency using elevated plus maze, and decrease in escape latency during training and increase in time spent in target quadrant during retrieval using Morris water maze. The drugs did not show any significant effect on locomotor activity of the mice. Memory-enhancing activity of palmatine (1 mg/kg) was comparable to physostigmine. Palmatine (1 mg/kg) significantly reversed scopolamine- and diazepam-induced amnesia in mice. Palmatine and physostigmine also significantly reduced brain acetylcholinesterase activity of mice. Thus, palmatine showed memory-enhancing activity in mice probably by inhibiting brain acetylcholinesterase activity, through involvement of GABA-benzodiazepine pathway, and due to its antioxidant activity.
Highlights
Dementia, the commonest form of which is Alzheimer’s disease (AD), mainly affects older people and it is estimated that, by 2050, more than 115 million people will have dementia [1]
Each animal was subjected to training trials for four consecutive days, the starting position was changed with each exposure as mentioned below and target quadrant (Q4 in the present study) remained constant throughout the training period
Effect of Palmatine and Other Drugs Employed on Transfer Latency (TL) of Mice
Summary
The commonest form (accounting for approximately 60% of all cases) of which is Alzheimer’s disease (AD), mainly affects older people and it is estimated that, by 2050, more than 115 million people will have dementia [1]. The primary causes of AD appear to be (i) decreased cholinergic activity; (ii) deposition of amyloid-beta peptides in the brain; (iii) oxidative stress. Acetylcholinesterase (AChE) plays a key role in the regulation of the cholinergic system and inhibition of AChE has emerged as one of the most promising strategies for the treatment of AD. One of the major therapeutic strategies is to inhibit the AChE, and to increase the acetylcholine level in the brain [3]. It is typically yellow in color and is an active constituent of a number of plants, such as Coptidis rhizoma [5], and so forth. Palmatine has been reported to possess sedative [6] and antioxidant activities [5]. The present study was designed to investigate the effect of palmatine on the learning and memory of mice by employing behavioral models
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
